Auctus Biologics' Seed Round

Auctus Biologics raised a round of funding on September 21, 2018.

Auctus Biologics, a portfolio company of Ichor Therapeutics, is a biotechnology company that creates new therapies using antibody mimetic scaffolds based on RPtag.…

Articles about Auctus Biologics' Seed Round: